Wegovy (semaglutide): Complete Guide 2026
Wegovy (semaglutide 2.4mg) is a once-weekly injectable GLP-1 receptor agonist specifically approved for chronic weight management. It is the higher-dose version of semaglutide, the same active ingredient in Ozempic. In the landmark STEP clinical trials, Wegovy demonstrated an average weight loss of approximately 16-17% of body weight over 68 weeks, making it one of the most effective anti-obesity medications available.
Enzo's Tip
Patience is the name of the game with Wegovy! You'll spend 16 weeks slowly climbing to the full 2.4mg dose — think of it like Enzo stalking a toy mouse, slow and steady wins the prize. Don't rush the dose escalation, your tummy will thank you! 🐱
Track your Wegovy journey with Enzo
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Quick Facts
| Generic Name | semaglutide |
| Manufacturer | Novo Nordisk |
| Type | Injectable pen |
| Frequency | Once weekly |
| Primary Indication | Chronic weight management |
Wegovy Guides
Get Wegovy prescribed online — most patients approved in 24 hours
Licensed providers, no in-person visit, medication shipped to your door.
Enzo reminds you when your next Wegovy dose is due
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Frequently Asked Questions
The guide your doctor doesn't have time to give you
Your complete Wegovy playbook: week-by-week guide, what to eat when nothing sounds good, and how to manage every side effect. Free.
No spam. Unsubscribe anytime.
Medical Disclaimer: Enzo is a tracking companion, not a doctor. Always consult your healthcare provider before starting, stopping, or changing any medication. The information on this page is for educational purposes only and should not be considered medical advice. Individual results may vary.